Tilray stock jumps nearly 32 percent in Nasdaq's first cannabis IPO

The international backing of institutional investors signaled changing perceptions for the cannabis industry, Tilray's CEO said.

Source: bizjournals.com Health Care:Biotechnology headlines - July 19, 2018 Category: Biotechnology Authors: Casey Coombs Source Type: news